| DB ID | MyCo_3913 |
| Title | Sensitization to Aspergillus fumigatus as a risk factor for bronchiectasis in COPD |
| Year | 2017 |
| PMID | 28919731 |
| Fungal Diseases involved | Aspergillus fumigatus infection |
| Associated Medical Condition | Bronchiectasis–chronic obstructive pulmonary disease (COPD) |
| Genus | Aspergillus |
| Species | fumigatus |
| Organism | Aspergillus fumigatus |
| Ethical Statement | The study was approved by the local ethics committee (Medical Ethical Board of the University Hospitals Leuven, Belgium – ML11081), and all patients provided written informed consent. |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Plasma |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | IgG |
| Biomarker Full Name | Immunoglobulin G |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Belgium |
| Cohort | This observational study investigated sensitization to A fum in an outpatient clinical cohort of 300 COPD patients and 50 (ex-) smoking controls. |
| Cohort No. | 300 Patient and 50 control |
| Age Group | None |
| P Value | p=0.0473 |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | Immunological assay |
| Analysis Method | ImmunoCAP fluoroenzyme immunoassay |
| ELISA kits | None |
| Assay Data | None |
| Validation Techniques used | ImmunoCAP fluoroenzyme immunoassay |
| Up Regulation Down Regulation | Increase |
| Sequence Data | None |
| External Link | None |
